SRPT
insider transactionsSarepta Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 90d
-
Grant·A
Director
—
16.9K sh
Own +67%
-
Grant·A
Director
—
16.9K sh
Own +54%
-
Grant·A
Director
—
16.9K sh
Own +956%
-
Grant·A
Director
—
16.9K sh
Own +323%
-
Grant·A
Director
—
16.9K sh
Own +158%
-
Grant·A
Director
—
16.9K sh
Own +204%
-
Grant·A
Director
—
16.9K sh
Own +1%
-
Grant·A
Director
—
16.9K sh
Own +9%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Wigzell Hans Lennart Rudolf | Grant A | 16.9K | — |
| Jun 4, 2026 | Nicaise Claude | Grant A | 16.9K | — |
| Jun 4, 2026 | Mayo Stephen | Grant A | 16.9K | — |
| Jun 4, 2026 | Connelly Deirdre P | Grant A | 16.9K | — |
| Jun 4, 2026 | Chambers Michael Andrew | Grant A | 16.9K | — |
| Jun 4, 2026 | Boor Kathryn Jean | Grant A | 16.9K | — |
| Jun 4, 2026 | Barry Richard | Grant A | 16.9K | — |
| Jun 4, 2026 | BEHRENS M KATHLEEN | Grant A | 16.9K | — |
Buy Sell Non-market (grant · exercise · gift)
About SRPT insider trading
This page tracks insider transactions for Sarepta Therapeutics, Inc. (SRPT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.